Human Microbiome Market To Witness Exponential Growth $8300.65 Mn By 2032

According to findings of Zion Market Research study, Human Microbiome industry accumulated revenue of nearly USD 743.1 Million in 2023, with projections indicating that it will reach USD 8300.65 Million by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 27.3% over the forecast period 2024-2032. Furthermore, growth of human microbiome market over assessment period is subject to high focus on human microbiome therapeutics development.

In addition to this, development of human-microbiome-based clinical trials for detecting disease at initial phase will steer expansion of human microbiome industry. Furthermore, surge in funding activities and favorable government initiatives along with increase in efforts made by pharma firms for developing pharma medicines will augment human microbiome industry. Apart from this, increase in aging population and prominent rise in capital funding in research activities carried out by biotech & biopharmaceutical firms will steer elevation of human microbiome industry in ensuing years.

Therapeutics Segment To Dominate Application Landscape Over 2024-2032

Human microbiome therapeutics has been utilized immensely while treating crohn’s disorder, COVID-19 ailment, diabetes, c. difficile infection, and inflammatory bowel disease. Additionally, growing efforts made by pharma firms for developing new medicines is predicted to favorably leverage growth of segment over ensuing years.

North America To Make Lucrative Contributions Towards Overall Market Size By 2032

Expansion of human microbiome industry in North America over assessment period can be owing to surge in cases of lifestyle-related ailments as well as auto-immune disorders. Additionally, presence of robust drug pipeline can be credited to lucrative growth of regional market over forthcoming years. Reportedly, in 2019, Canadian government allocated funds worth USD 18.1 million for microbiome research activities pertaining to diabetes, childhood asthma, malnutrition, cervical cancer, and inflammatory bowel disease.

Key players leveraging growth of human microbiome market and profiled in study are Rebiotix, Inc., uBiome, Inc., Osel, Inc., Enterome Biosciences, OBiome LLC, Vedanta Biosciences, Seres Therapeutics, Second Genome, Metabiomics Corp., and Synthetic Biologics, Inc. 

Browse the full “Human Microbiome Market - By Product (Probiotics, Prebiotics, Medical Foods, And Supplements), By Application (Therapeutics And Diagnostics) And By Disease Type (Obesity, Diabetes, Autoimmune Disorder, Metabolic & Gastrointestinal Disorders, And Cancer): Global Industry Perspective, Comprehensive Analysis And Forecast, 2024 – 2032.” Report at https://www.zionmarketresearch.com/report/human-microbiome-market

The global Human Microbiome Market is segmented as follows:

By Product

• Probiotics
• Prebiotics
• Medical Foods
• Supplements

By Disease Type

• Obesity
• Diabetes
• Autoimmune Disorder
• Metabolic & Gastrointestinal Disorders
• Cancer

By Application

• Therapeutics
• Diagnostics

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com